Literature DB >> 32415384

A cost analysis of a community-based support centre for cancer patients and their families in Ireland: the EVeCANs study.

Aileen Murphy1, Ryan W Chu2, Frances J Drummond3.   

Abstract

Cancer patients and their families experience a range of physical, psychological and financial adverse effects. Community-based cancer centres offer a range of services and interventions, free of charge, to support those affected by cancer. While shown to be effective, there is a lack of information on the costs of these services. Our aim was to estimate the resource impact of a community-based cancer support centre. Over a 7-month period, there were 2032 contacts with 238 clients whose average age was 60 years. The most frequently used services were transport to treatment (20%), complementary therapies (48%), exercise classes (10%) and counselling (9%). This cost analysis estimated total annual cost to provide all services was €313,744. Average annual cost per person was €1138. Current uptake at the centre represents 8% of all cancer incidences in seven counties surrounding the centre. If uptake increases by 10%, scenario analyses predict an increase in total costs increase to €429,043 and a decrease in costs per patient to €915. As cancer incidences increase, the need for supportive care is growing. Community-based services have been established to meet these needs and fill this gap in national health services. Long-term sustainability of these centres is uncertain as they are entirely reliant on donations and volunteers. This analysis estimates the costs of one such community-based cancer support centre, for the first time in Ireland. Findings can be used to inform future planning of cancer supportive care services, including establishing links between tertiary and community-based centres, and cost effectiveness analyses, nationally and internationally.

Entities:  

Keywords:  Community; Costs; Families; Patients; Support

Mesh:

Year:  2020        PMID: 32415384     DOI: 10.1007/s00520-020-05508-8

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  7 in total

Review 1.  Complementary alternative medicine (CAM) use in Ireland: a secondary analysis of SLAN data.

Authors:  Patricia Fox; Barbara Coughlan; Michelle Butler; Cecily Kelleher
Journal:  Complement Ther Med       Date:  2010-03-01       Impact factor: 2.446

2.  Survivorship care for postmenopausal breast cancer patients in Ireland: What do women want?

Authors:  Elizabeth Meade; Sonja McIlfatrick; Ann Marie Groarke; Eimear Butler; Maura Dowling
Journal:  Eur J Oncol Nurs       Date:  2017-04-01       Impact factor: 2.398

3.  Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies.

Authors:  Barbara Rehse; Ralf Pukrop
Journal:  Patient Educ Couns       Date:  2003-06

4.  The National Cancer Survivorship Initiative: new and emerging evidence on the ongoing needs of cancer survivors.

Authors:  M Richards; J Corner; J Maher
Journal:  Br J Cancer       Date:  2011-11-08       Impact factor: 7.640

5.  Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960.

Authors:  A S Ahmad; N Ormiston-Smith; P D Sasieni
Journal:  Br J Cancer       Date:  2015-02-03       Impact factor: 7.640

6.  High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research.

Authors:  Felix H Fischer; George Lewith; Claudia M Witt; Klaus Linde; Klaus von Ammon; Francesco Cardini; Torkel Falkenberg; Vinjar Fønnebø; Helle Johannessen; Bettina Reiter; Bernhard Uehleke; Wolfgang Weidenhammer; Benno Brinkhaus
Journal:  BMC Complement Altern Med       Date:  2014-02-06       Impact factor: 3.659

7.  Mode of prostate cancer detection is associated with the psychological wellbeing of survivors: results from the PiCTure study.

Authors:  Frances J Drummond; Eamonn O'Leary; Anna Gavin; Heather Kinnear; Linda Sharp
Journal:  Support Care Cancer       Date:  2015-11-23       Impact factor: 3.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.